secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001493152-23-025596
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa prices $2.1M public offering and extends investor lockup
----------------------------------------------------------------

- Priced 'reasonable best efforts' public offering of ~12.7M shares/pre-funded warrants plus common warrants at $0.165/unit for ~$2.1M gross proceeds.
- Common warrants exercisable at $0.165 for 5 years; pre-funded warrants exercisable at $0.0001 until exercised.
- Amended April 2023 warrants to reduce exercise price from $1.00 to $0.165 and extend expiration to match new warrants.
- Issued 3,044,152 lockup extension shares to certain investors in private placement to extend lockup to July 31, 2023.
- Net proceeds intended for working capital and possible redemption of Series A preferred stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/0001493152-23-025596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer